PET/CT for Early Detection of COVID-19 Pneumonia: Diffuse Fluorodeoxyglucose Uptake in the Lungs without any Additional Changes in a Patient with Breast Cancer

• Published in: Molecular imaging and radionuclide therapy Vol. 30; no. 3; pp. 197 - 200
• Main Authors: Özdemir, Büşra, Günay, Burak, Karabulut, Derya, Durmuş Altun, Gülay
• Format: Journal Article
• Language: English
• Published: Ankara Galenos Publishing House 01-10-2021; Galenos Publishing
• Subjects: Breast cancer; Computed tomography; Conflicts of interest; Consent; Coronaviruses; COVID-19; Fluorine isotopes; Interesting Image; Nuclear medicine; Pandemics; Pneumonia; Positron emission; Positron emission tomography; Respiratory distress syndrome; Respiratory tract; Viral diseases
• ISSN: 2146-1414; 2147-1959
• DOI: 10.4274/mirt.galenos.2021.15013

Coronavirus disease-2019 (COVID-19), which causes infections in the upper and lower respiratory tract, became a pandemic shortly after it was first diagnosed in Wuhan city, China. Many people are affected with high mortality rates and severe respiratory distress syndrome. During this pandemic, all physicians paid attention to the findings of COVID-19. Suggestive findings in 18fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) were characterized as increased 18F-FDG uptake in bilateral peripheral consolidative areas and ground glass opacities. We aimed to show diffuse FDG uptake in PET images with indefinable lesions in CT as a suspicious finding for early COVID-19.